Filing Details
- Accession Number:
- 0001140361-16-058107
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-16 19:26:39
- Reporting Period:
- 2016-03-15
- Filing Date:
- 2016-03-16
- Accepted Time:
- 2016-03-16 19:26:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1416792 | Relypsa Inc | RLYP | Pharmaceutical Preparations (2834) | 260893742 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591464 | J. Thomas Schuetz | C/O Relypsa, Inc. 100 Cardinal Way Redwood City CA 94063 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-15 | 30,000 | $13.39 | 33,962 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $13.365 to $13.42, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
- Includes 2,250 RSUs.